Starting Dose for Gabapentin in Neuropathic Pain
Start gabapentin at 100-300 mg at bedtime OR 100-300 mg three times daily, then increase by 100-300 mg every 1-7 days as tolerated. 1
Recommended Dosing Algorithm
Initial Dosing (Choose One Approach)
Standard FDA-approved regimen for postherpetic neuralgia:
- Day 1: 300 mg once daily
- Day 2: 600 mg/day (300 mg twice daily)
- Day 3: 900 mg/day (300 mg three times daily)
- Then titrate to 1800 mg/day (600 mg three times daily) as needed 2
Alternative conservative approach:
- Start with 100-300 mg at bedtime OR 100-300 mg three times daily
- Increase by 100-300 mg every 1-7 days based on tolerability 1
Target Maintenance Dose
- Effective range: 1800-3600 mg/day in three divided doses
- Optimal dose: 1800 mg/day provides comparable efficacy to higher doses with better tolerability 2
- Maximum dose: 3600 mg/day (though additional benefit above 1800 mg/day is not consistently demonstrated) 1
Key Clinical Considerations
Titration Timeline
- Allow 3-8 weeks for titration plus 2 weeks at maximum tolerated dose before determining treatment failure 1
- An adequate trial can require 2 months or more 1
- Maximum time between doses should not exceed 12 hours 2
Special Populations
Elderly patients:
- Use lower starting doses and slower titration 1
- Adjust dose based on creatinine clearance (elderly have higher risk of renal impairment) 2
Renal impairment (critical adjustment required):
- CrCl ≥60 mL/min: 900-3600 mg/day (300 mg TID standard dosing)
- CrCl 30-59 mL/min: 400-1400 mg/day (200-700 mg BID)
- CrCl 15-29 mL/min: 200-700 mg/day (200-700 mg once daily)
- CrCl <15 mL/min: 100-300 mg once daily 2
Common Pitfalls to Avoid
Titrating too rapidly: Dose-dependent dizziness and sedation are common but can be minimized with gradual titration 1
Stopping too early: Most side effects are transient and occur during titration phase, typically subsiding within 10 days 3, 4
Inadequate trial duration: Don't declare treatment failure before completing at least 6-8 weeks with 2 weeks at maximum tolerated dose 1
Abrupt discontinuation: Always taper gradually over minimum 1 week to avoid withdrawal symptoms 2
Ignoring renal function: Gabapentin requires mandatory dose adjustment in renal impairment due to renal excretion 2
Evidence Quality Note
The FDA labeling 2 and Mayo Clinic guidelines 1 provide concordant recommendations. Research evidence supports that starting doses of 600 mg/day can be safe and effective 5, and that 900 mg/day is an appropriate initial target with titration to 1800 mg/day for optimal efficacy 3. The highest quality meta-analysis found substantial benefit (≥50% pain relief) with gabapentin ≥1200 mg/day compared to placebo in postherpetic neuralgia (RR=1.8) and painful diabetic neuropathy (RR=1.9) 6.